To save their friends, they must break into the legendary Last City, a WCKD-controlled labyrinth that may turn out to be the deadliest maze of all. Anyone who makes it out alive will get answers ...

"I couldn't stand seeing all those dead animals." With help from a close friend, she launched the Chileno Valley Newt Brigade. Now about 80 volunteers strong, the grassroots group has for six ...

On Tuesday, Morin made a post on X that further addressed the advisor’s status as a trans runner. “Trans folks only want to fully integrate as their authentic self and be happy, in our society ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...

Obesity biotech Metsera and renal and metabolic-focused Maze Therapeutics have met their IPO expectations as the two companies prepare to join the Nasdaq this morning. While Metsera is offering ...

BOCA RATON, Fla., Feb. 18, 2025 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (NASDAQ: NEWT) announced today that Newtek Advantage® now integrates with Intuit QuickBooks®, providing independent business ...

Jacob Kiplimo shattered the half marathon world record with a blistering run on Sunday. The 24-year-old Ugandan was competing in the Barcelona half marathon where he became the first person ever ...

Rochester Institute of Technology (RIT) transgender runner Sadie Schreiner boasted about a victory at a women’s track and field meet over the weekend. Schreiner won the 200-meter event with a ...

The male victims were walking their dogs by Newt Pond, near School Road, and were then reportedly approached by two boys, Suffolk police said. In the second incident, one of the victims was ...

A baby newt in northern California, 2024. Starting in late fall each year, migrating newts have to cross a public road that divides their forested hillside habitat from their spawning ground in a ...

Maze seeks as much as $133 mln in New York IPO Backers include Alphabet's GV and Third Rock Ventures Biotech IPOs set for ramp up in coming weeks Jan 27 (Reuters) - Drug developer Maze ...